Cargando…
Personalization of medicine requires better observational evidence
Evidence-based medicine has become associated with a preference for randomized trials. Randomization is a powerful tool against both known and unknown confounding. However, due to cost-induced constraints in size, randomized trials are seldom able to provide the subgroup analyses needed to gain much...
Autores principales: | Middelburg, Rutger A, Arbous, M Sesmu, Middelburg, Judith G, van der Bom, Johanna G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174902/ https://www.ncbi.nlm.nih.gov/pubmed/30323682 http://dx.doi.org/10.2147/CLEP.S167137 |
Ejemplares similares
-
Personalized Medicine in Epidemics
por: Middelburg, Rutger A.
Publicado: (2022) -
Thrombocytopenia and bleeding in myelosuppressed transfusion-dependent patients: a simulation study exploring underlying mechanisms
por: Middelburg, Rutger A, et al.
Publicado: (2018) -
Risk factors for bleeding in haemato-oncology patients—a nested case–control study: The BITE study protocol (Bleeding In Thrombocytopenia Explained)
por: Cornelissen, Loes L, et al.
Publicado: (2020) -
COVID-19: How to make between-country comparisons
por: Middelburg, Rutger A., et al.
Publicado: (2020) -
Predicting organ functioning with and without blood transfusion in critically ill patients with anemia
por: Kranenburg, Floris J., et al.
Publicado: (2022)